Seeing Is Believing
LUMO is currently covered by 3 analysts with an average price target of $-3.26. This is a potential upside of $-5.78 (-229.37%) from yesterday's end of day stock price of $2.52.
Lumos Pharma's activity chart (see below) currently has 25 price targets and 32 ratings on display. The stock rating distribution of LUMO is 85.71% BUY and 14.29% HOLD.
Analysts average stock forecasts to be materialized ratio is 64.83% with an average time for these price targets to be met of 267.8 days.
Highest price target for LUMO is $10, Lowest price target is $10, average price target is $-3.26.
Most recent stock forecast was given by LELAND GERSHELL from OPPENHEIMER on 11-Dec-2023. First documented stock forecast 10-May-2016.
Currently out of the existing stock ratings of LUMO, 6 are a BUY (85.71%), 1 are a HOLD (14.29%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4 months 6 days ago
0/1 (0%)
$12.65 (172.11%)
Buy
10
$7.35 (277.36%)
10
7 months 27 days ago
1/4 (25%)
$7.03 (236.70%)
28
Hold
7
$4.35 (164.15%)
7
1 years 4 months 10 days ago
2/4 (50%)
$2.8 (66.67%)
79
Buy
26
1 years 5 months 4 days ago
2/5 (40%)
$17.95 (222.98%)
182
Buy
28
2 years 5 months 8 days ago
1/3 (33.33%)
$18.49 (194.43%)
148
What is LUMO (Lumos Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on LUMO (Lumos Pharma) with a proven track record?
Which analyst has the most public recommendations on LUMO (Lumos Pharma)?
Which analyst is the currently most bullish on LUMO (Lumos Pharma)?
Which analyst is the currently most reserved on LUMO (Lumos Pharma)?